Barinthus Biotherapeutics

NASDAQ: BRNS · Real-Time Price · USD
1.26
-0.02 (-1.25%)
At close: Aug 15, 2025, 3:59 PM
1.33
5.97%
Pre-market: Aug 18, 2025, 07:10 AM EDT

Barinthus Biotherapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.78 -1.93 16.39 -8.12
PEG Ratio
0.04 0.00 -0.15 0.08
PS Ratio
3.18 176.61 1.96 1.54K
PB Ratio
0.37 0.76 0.36 1.64
P/FCF Ratio
-1.6 -2.51 -4.26 -12.25
P/OCF Ratio
-1.65 -2.78 -6.07 -12.68
OCF/S Ratio
-1.93 -63.5 -0.32 -121.58
Debt / Equity Ratio
0.09 0.07 0.04 0.03
Quick Ratio
8.03 12.45 17.40 20.32
Current Ratio
8.03 12.45 17.40 20.32
Asset Turnover
0.09 0.00 0.17 0.00
Interest Coverage
-1.28K -3K -212.68 -16.95
Return on Equity
-0.47 -0.39 0.02 -0.2
Return on Assets
-0.38 -0.34 0.02 -0.18
Return on Invested Capital
-0.46 -0.4 -0.1 -0.17
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.61 -5.79 1.00 1.00
Net Profit Margin
-4.08 -91.46 0.12 -189.79
Pretax Profit Margin
-4.09 -95.41 0.02 -190.82
Operating Profit Margin
-4.54 -104.63 -0.09 -168.74
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-3.7 -88.61 0.14 -178.62